Skip to Main Content
Table 2

Microsatellite analysis of clinical samples by T-stage of the tumor at the time of surgerya

Sample (n = 28)Stage of tumor
All T-Stages (n = 28)pT1 (n = 3)pT2 (n = 12)pT3 & pT4 (1) (n = 13)P                  b
Tumor LOH/SHIFT 26 (92.9) 2 (66.7) 11 (91.7) 13 (100) 0.12 n.s. 
 Tumor 1–2 5 (17.9) 0 (0) 2 (16.7) 2 (15.4) 0.22 n.s. 
 Tumor > 2 21 (75) 2 (66.7) 10 (83.4) 11 (84.6) 0.16 n.s. 
Serum LOH/SHIFT 27 (96.4) 3 (100) 11 (91.7) 13 (100) 0.50 n.s. 
 Serum 1–2 8 (28.6) 1 (33.3) 2 (16.7) 5 (38.5) 0.32 n.s. 
 Serum > 2 20 (71.4) 2 (66.7) 10 (83.4) 8 (61.5) 0.62 n.s. 
Sample (n = 28)Stage of tumor
All T-Stages (n = 28)pT1 (n = 3)pT2 (n = 12)pT3 & pT4 (1) (n = 13)P                  b
Tumor LOH/SHIFT 26 (92.9) 2 (66.7) 11 (91.7) 13 (100) 0.12 n.s. 
 Tumor 1–2 5 (17.9) 0 (0) 2 (16.7) 2 (15.4) 0.22 n.s. 
 Tumor > 2 21 (75) 2 (66.7) 10 (83.4) 11 (84.6) 0.16 n.s. 
Serum LOH/SHIFT 27 (96.4) 3 (100) 11 (91.7) 13 (100) 0.50 n.s. 
 Serum 1–2 8 (28.6) 1 (33.3) 2 (16.7) 5 (38.5) 0.32 n.s. 
 Serum > 2 20 (71.4) 2 (66.7) 10 (83.4) 8 (61.5) 0.62 n.s. 
a

Number (%) of LOH or SHIFT in the sample.

b

χ2-test.

View Large
Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal
This site uses cookies. By continuing to use our website, you are agreeing to our privacy policy.
Accept